Miami VA Healthcare System

Running trials

• Recruiting

  Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

  NCT06953726· Phase 4· VA Office of Research and Development· Source

• Recruiting

  Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

  NCT07168993· bioAffinity Technologies Inc.· Source

• Recruiting

  PSMA PET for the Staging and Management of Hepatocellular Carcinoma

  NCT07019844· VA Office of Research and Development· Source

• Recruiting

  Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  NCT05486572· VA Office of Research and Development· Source

• Active, not recruiting

  A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

  NCT05904886· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

  NCT04419272· Phase 4· VA Office of Research and Development· Source

• Recruiting

  Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  NCT02915198· Phase 4· VA Office of Research and Development· Source

• Enrolling by invitation

  Testing a Novel Dry Electrode Headset for Electroencephalography Telehealth

  NCT05380921· VA Office of Research and Development· Source

• Recruiting

  Treatments for Insomnia in Veterans With PTSD

  NCT05194930· VA Office of Research and Development· Source

• Active, not recruiting

  Longitudinal Bladder Cancer Study for Tumour Recurrence

  NCT05080998· Pacific Edge Limited· Source

• Active, not recruiting

  ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

  NCT05064553· Exact Sciences Corporation· Source

• Active, not recruiting

  Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

  NCT04380636· Phase 3· Merck Sharp & Dohme LLC· Source

• Active, not recruiting

  Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma

  NCT03878550· Glycotest, Inc.· Source

• Recruiting

  Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  NCT02984761· VA Office of Research and Development· Source

• Active, not recruiting

  Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)

  NCT01239082· VA Office of Research and Development· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy2 recruiting
• Liver and biliary tract cancer2 recruiting
• Lung cancer2 recruiting
• Atrial fibrillation1 recruiting
• Coronary artery disease1 recruiting
• Liver cirrhosis1 recruiting
• Peripheral artery disease1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

  NCT06039189· Phase 3· Janssen Research & Development, LLC· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Long COVID and ME/CFS9 works · 0 trials